Moutaz Derbala

Summary

Publications

  1. doi request reprint Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 15:591-9. 2008
  2. ncbi request reprint Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    M Derbala
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 12:380-5. 2005
  3. pmc Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, PO Box 3050, Doha, 00974, State of Qatar
    World J Gastroenterol 16:1226-31. 2010
  4. pmc Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital and Weill Cornell Medical College in Qatar, Egypt
    J Viral Hepat 18:e258-62. 2011
  5. ncbi request reprint Myalgia during interferon therapy--does it warrant monitoring muscle enzymes?
    Anil John
    Department of Gastroenterology, Medical Research Centre, Hamad Medical Corporation, Doha, Qatar
    Trop Gastroenterol 30:175-6. 2009
  6. doi request reprint The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients
    Moutaz Derbala
    Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar Medical Department, Weill Cornell Medical College, Qatar Branch, Doha, Qatar Electronic address
    Virology 444:292-300. 2013
  7. pmc Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital, Doha 3050, Qatar
    World J Gastroenterol 18:7003-8. 2012

Collaborators

  • A Bener
  • Anil John
  • Rajvir Singh
  • Anjum S John
  • Kaabi Saad Al
  • Rafie Yakoub

Detail Information

Publications7

  1. doi request reprint Viral kinetic of HCV genotype-4 during pegylated interferon alpha 2a: ribavirin therapy
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 15:591-9. 2008
    ..Those unfortunate cases who do not achieve viral clearance by week 1 or week 4 should not be deprived from the treatment but rather given more time till week 12 before being classified as non-responders...
  2. ncbi request reprint Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis
    M Derbala
    Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar
    J Viral Hepat 12:380-5. 2005
    ....
  3. pmc Microalbuminuria in hepatitis C-genotype 4: effect of pegylated interferon and ribavirin
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Medical Corporation, PO Box 3050, Doha, 00974, State of Qatar
    World J Gastroenterol 16:1226-31. 2010
    ....
  4. pmc Hepatitis C virus genotype 4 with normal transaminases: histological changes, schistosomiasis and response to treatment
    M F Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital and Weill Cornell Medical College in Qatar, Egypt
    J Viral Hepat 18:e258-62. 2011
    ..Severe fibrosis is a strong and independent predictor of response to treatment. Therefore, it is important to treat individuals with PNALT levels regardless of schistosomiasis...
  5. ncbi request reprint Myalgia during interferon therapy--does it warrant monitoring muscle enzymes?
    Anil John
    Department of Gastroenterology, Medical Research Centre, Hamad Medical Corporation, Doha, Qatar
    Trop Gastroenterol 30:175-6. 2009
    ..This excluded the possibility of subclinical myositis in myalgic patients and thus led us to conclude that routine monitoring of muscles enzymes is neither necessary nor beneficial...
  6. doi request reprint The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients
    Moutaz Derbala
    Gastroenterology and Hepatology Department, Hamad Hospital, Doha, Qatar Medical Department, Weill Cornell Medical College, Qatar Branch, Doha, Qatar Electronic address
    Virology 444:292-300. 2013
    ..Interleukin-28B (IL28B) polymorphisms have previously been reported to be strongly associated with spontaneous and treatment-induced HCV viral clearance...
  7. pmc Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis
    Moutaz Derbala
    Department of Gastroenterology and Hepatology, Hamad Hospital, Doha 3050, Qatar
    World J Gastroenterol 18:7003-8. 2012
    ..To investigate the association between interleukin-28B (IL28B) genotype and response to treatment and hepatic fibrosis in patients with hepatitis C virus (HCV) genotype 4...